BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26854205)

  • 1. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.
    Wagner M; Sjöberg K; Vigren L; Olesen M; Benoni C; Toth E; Carlson M
    Scand J Gastroenterol; 2016 Jul; 51(7):835-41. PubMed ID: 26854205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
    Wagner M; Peterson CG; Stolt I; Sangfelt P; Agnarsdottir M; Lampinen M; Carlson M
    Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level.
    Peterson CG; Lampinen M; Hansson T; Lidén M; Hällgren R; Carlson M
    Scand J Clin Lab Invest; 2016 Sep; 76(5):393-401. PubMed ID: 27223407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.
    Wagner M; Peterson CG; Ridefelt P; Sangfelt P; Carlson M
    World J Gastroenterol; 2008 Sep; 14(36):5584-9; discussion 5588. PubMed ID: 18810778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.
    Peterson CG; Eklund E; Taha Y; Raab Y; Carlson M
    Am J Gastroenterol; 2002 Jul; 97(7):1755-62. PubMed ID: 12135031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
    Blom K; Rubin J; Halfvarson J; Törkvist L; Rönnblom A; Sangfelt P; Lördal M; Jönsson UB; Sjöqvist U; Håkansson LD; Venge P; Carlson M
    World J Gastroenterol; 2012 Nov; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
    Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
    Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.
    Pucci N; Lombardi E; Novembre E; Farina S; Bernardini R; Rossi E; Favilli T; Vierucci A
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):353-7. PubMed ID: 10669858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic study in adults with food hypersensitivity assessed as eosinophil activation in fecal samples.
    Magnusson J; Gellerstedt M; Ahlstedt S; Andersson B; Bengtsson U; Telemo E; Hansson T; Peterson CG
    Clin Exp Allergy; 2003 Aug; 33(8):1052-9. PubMed ID: 12911778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
    Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
    Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis.
    Tischendorf FW; Brattig NW; Burchard GD; Kubica T; Kreuzpaintner G; Lintzel M
    Acta Trop; 1999 Mar; 72(2):157-73. PubMed ID: 10206116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.
    Peterson CG; Sangfelt P; Wagner M; Hansson T; Lettesjö H; Carlson M
    Scand J Clin Lab Invest; 2007; 67(8):810-20. PubMed ID: 18034391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
    Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
    Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of serological markers of activated eosinophils in inflammatory bowel diseases.
    Dainese R; Galliani EA; De Lazzari F; D'Incà R; Mariné-Barjoan E; Vivinus-Nebot MH; Hébuterne X; Sturniolo GC; Piche T
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):393-7. PubMed ID: 22293328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel disease.
    Amcoff K; Cao Y; Zhulina Y; Lampinen M; Halfvarson J; Carlson M
    Scand J Gastroenterol; 2019 Oct; 54(10):1237-1244. PubMed ID: 31577465
    [No Abstract]   [Full Text] [Related]  

  • 18. The production of the eosinophil proteins ECP and EPX/EDN are regulated in a reciprocal manner.
    Jönsson UB; Blom K; Stålenheim G; Håkansson LD; Venge P
    APMIS; 2014 Apr; 122(4):283-91. PubMed ID: 24738159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.
    Bischoff SC; Grabowsky J; Manns MP
    Dig Dis Sci; 1997 Feb; 42(2):394-403. PubMed ID: 9052525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
    Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
    Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.